Skip to main content
. 2022 Aug 30;13:998236. doi: 10.3389/fimmu.2022.998236

Figure 3.

Figure 3

Prognostic potential of cuproptosis-signature. (A) The violin figures for comparing the CuproptosisScore of TCGA patients among WHO grades, mutation status and MGMT methylation status. (B) Kaplan-Meier survival curve showing survival probability of high-CuproptosisScore or low-CuproptosisScore subgroups. (C) The forest figure for Univariate or Multivariate Cox regression analysis of CuproptosisScore and clinicopathologic features. (D) The 1-year, 2-year, 3-year, 4-year, and 5-year survival ROC curves are predicted by the cuproptosis-signature. (E) Univariate Cox regression analysis of the cuproptosis-signature in 11 external validation data sets. ***P < 0.001.